Paul Romesser, MD

Memorial Sloan Kettering Cancer Center
New York, NY, United States

Dr. Romesser is an Assistant Member of Memorial Sloan Kettering Cancer Center in the Department of Radiation Oncology and the Early Drug Development Service in the Department of Medicine. He is a physician scientist with an interest the development of radiation sensitizers and mitigators for gastrointestinal cancers. Dr. Romesser is a member of the NRG Oncology colorectal and non-colorectal committees. He is involved in industry and NCI sponsored corporative group clinical trials in rectal and anal cancer.

Disclosures:

• Employment: Memorial Sloan Kettering Cancer Center:Assistant Attending:Employee
• Compensation: EMD Serono: Consultant, Research Grants, Research Funding, Research Salary Support, Compensation Payment-End Date: to present ;Faeth Therapeutics: Consultant, Compensation Payment-End Date: to present ;X Rad Therapeutics: Research Grants, Research Funding, Research Salary Support,Research Role Description Topic-End Date: to present ;Natera: Consultant, Compensation Payment-End Date: to present
• Ownership: none
• Leadership: HPV Cancers Alliance:SAB member;Anal Cancer Foundation:SAB member

Presentation(s):

• 3067 - Alliance A022101/NRG-GI009: A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer - Evaluating Radiation, Ablation and Surgery

  Tuesday, October 1, 2024
  12:45 PM – 2:00 PM ET